Delivery Order SPE2DB20D2104-SPE2DB25FMYAV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Provocholine inhalation solution in 18 mL packs. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by August 28, 2025. The product will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,100.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution in an 18ML pack. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction under the company's broader...
- The Defense Logistics Agency (DLA) awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML pack quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a non-set-aside competitive award, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Provocholine inhalation solution in 18ML packs under a firm fixed-price contract with a ceiling value of $1,804.77. This non-competitive delivery order is set to conclude on August 28, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Provocholine is a bronchial challenge agent used in pulmonary function...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution Pack (18ML) with a ceiling value of $2,526.72 under a firm fixed price contract type. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025, with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $16,503.90 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs. This delivery order, issued on July 19, 2025, with an ultimate completion date of July 21, 2025, operates under a firm fixed price structure with no set-aside designation. The award represents a competitive procurement action through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Provocholine 100 mg vials, with a ceiling value of $1,895.08 and a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,846,728 units of Provocholine inhalation solution. The $1,602.39 firm fixed-price contract has a period of performance through September 18, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 for delivering a comprehensive range of medical commodities to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $7,538.38 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 17, 2025, for Provocholine inhalation solution in 18-milliliter packs. The contract is set to be completed by September 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. This delivery order...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYAVDelivery Order
The Defense Logistics Agency awarded a $1,655.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ml packaging under contract 4569133382. The award, issued on August 18, 2025, with completion targeted for August 19, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. The contract is unset-aside and competitively awarded, with performance to occur at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support Defense Health Agency and other federal healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen demonstrates consistent capability to fulfill federal procurement requirements through competitive award processes and maintains a substantial portfolio of medical product deliveries across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/18/25 |